ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Prestige Consumer Healthcare, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.13% and Operating profit at 3.08% over the last 5 years
2
Flat results in Jun 25
- NET SALES(Q) Lowest at USD 249.53 MM
- OPERATING PROFIT(Q) Lowest at USD 79.42 MM
- NET PROFIT(Q) Lowest at USD 47.47 MM
3
With ROCE of 12.76%, it has a fair valuation with a 1.99 Enterprise value to Capital Employed
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -30.02%, its profits have risen by 6.6% ; the PEG ratio of the company is 3
4
Below par performance in long term as well as near term
- Along with generating -30.02% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Prestige Consumer Healthcare, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Prestige Consumer Healthcare, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Prestige Consumer Healthcare, Inc.
-30.02%
-0.30
28.62%
S&P 500
13.22%
0.65
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.13%
EBIT Growth (5y)
3.08%
EBIT to Interest (avg)
5.29
Debt to EBITDA (avg)
3.40
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.40
Tax Ratio
24.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.87%
ROE (avg)
14.20%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.48
EV to EBIT
15.63
EV to EBITDA
14.39
EV to Capital Employed
1.99
EV to Sales
4.80
PEG Ratio
3.01
Dividend Yield
NA
ROCE (Latest)
12.76%
ROE (Latest)
12.16%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 275.75 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 48.68 %
RAW MATERIAL COST(Y)
Fallen by -3.16% (YoY
CASH AND EQV(HY)
Highest at USD 237.39 MM
-5What is not working for the Company
NET SALES(Q)
Lowest at USD 249.53 MM
OPERATING PROFIT(Q)
Lowest at USD 79.42 MM
NET PROFIT(Q)
Lowest at USD 47.47 MM
EPS(Q)
Lowest at USD 0.95
Here's what is working for Prestige Consumer Healthcare, Inc.
Operating Cash Flow
Highest at USD 275.75 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at 48.68 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Cash and Eqv
Highest at USD 237.39 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -3.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Prestige Consumer Healthcare, Inc.
Net Sales
Lowest at USD 249.53 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Net Sales
At USD 249.53 MM has Fallen at -12.27%
over average net sales of the previous four periods of USD 284.44 MMMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit
Lowest at USD 79.42 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Net Profit
Lowest at USD 47.47 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD 0.95
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
